We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Ennis
EBF
$550M
| $404K | 0.06% |
20,655
-41,092
| -67% | -$801K |
|
|
HTD
527
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$918M
| $404K | 0.06% |
+17,735
| New | +$376K |
|
528
Lennar Class B
LEN.B
$20.1B
| $404K | 0.06% |
+11,208
| New | +$364K |
|
|
QLGC
529
DELISTED
QLOGIC CORP
QLGC
| $400K | 0.06% |
+29,747
| New | +$370K |
|
530
Tompkins Financial
TMP
$1.43B
| $398K | 0.06% |
+6,217
| New | +$355K |
|
531
AMERISAFE
AMSF
$562M
| $396K | 0.06% |
7,546
-45,286
| -86% | -$2.28M |
|
|
BCRH
532
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $395K | 0.06% |
+22,055
| New | +$398K |
|
533
Caesars Entertainment
CZR
$6.1B
| $394K | 0.06% |
34,404
+10,741
| +45% | +$112K |
|
|
JAX
534
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $394K | 0.06% |
+37,294
| New | +$364K |
|
|
TRST
535
Trustco Bank Corp NY
TRST
$978M
| $393K | 0.06% |
+12,975
| New | +$371K |
|
|
CEQP
536
DELISTED
Crestwood Equity Partners LP
CEQP
| $393K | 0.06% |
+33,703
| New | +$386K |
|
537
United Natural Foods
UNFI
$2.97B
| $392K | 0.06% |
+9,733
| New | +$359K |
|
|
AEGN
538
DELISTED
Aegion Corp
AEGN
| $392K | 0.06% |
18,571
-146,562
| -89% | -$2.74M |
|
539
Universal Electronics
UEIC
$57.6M
| $391K | 0.06% |
+6,312
| New | +$336K |
|
|
CKEC
540
DELISTED
Carmike Cinemas Inc
CKEC
| $391K | 0.06% |
13,001
-54,809
| -81% | -$1.33M |
|
541
Huntsman Corp
HUN
$2.06B
| $390K | 0.06% |
+29,353
| New | +$303K |
|
|
ATSG
542
DELISTED
Air Transport Services Group
ATSG
| $389K | 0.06% |
25,288
-1,212
| -5% | -$13.9K |
|
543
Graham Holdings Company
GHC
$5.08B
| $388K | 0.06% |
+809
| New | +$385K |
|
544
Mativ Holdings
MATV
$455M
| $388K | 0.06% |
12,335
-28,679
| -70% | -$1.03M |
|
|
CRAY
545
DELISTED
Cray, Inc.
CRAY
| $388K | 0.06% |
9,262
-31,736
| -77% | -$1.21M |
|
|
RSE
546
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $388K | 0.06% |
21,096
-38,971
| -65% | -$672K |
|
547
Dine Brands
DIN
$448M
| $385K | 0.06% |
+4,116
| New | +$361K |
|
|
TLN
548
DELISTED
Talen Energy Corporation
TLN
| $385K | 0.06% |
42,741
-70,225
| -62% | -$496K |
|
549
MasterCraft Boat Holdings
MCFT
$602M
| $384K | 0.06% |
+27,240
| New | +$347K |
|
550
Avis
CAR
$5.78B
| $383K | 0.06% |
+13,994
| New | +$382K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.